BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37831187)

  • 1. Pregnancy-specific beta-1-glycoprotein 6 is a potential novel diagnostic biomarker of placenta accreta spectrum.
    Kashiwagi H; Mariya T; Umemoto M; Ogawa S; Hirohashi Y; Fujibe Y; Kubo T; Someya M; Baba T; Ishioka S; Torigoe T; Saito T
    Med Mol Morphol; 2024 Mar; 57(1):35-44. PubMed ID: 37831187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States.
    Matsuzaki S; Mandelbaum RS; Sangara RN; McCarthy LE; Vestal NL; Klar M; Matsushima K; Amaya R; Ouzounian JG; Matsuo K
    Am J Obstet Gynecol; 2021 Nov; 225(5):534.e1-534.e38. PubMed ID: 33894149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizations and outcomes of intra-arterial balloon occlusion at cesarean hysterectomy for placenta accreta spectrum.
    Matsuo K; Matsuzaki S; Vestal NL; Sangara RN; Mandelbaum RS; Matsushima K; Klar M; Ouzounian JG
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2234-2243. PubMed ID: 34622939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outcome analysis of pregnancy termination and expectant treatment in pregnant women with suspected invasive placenta accreta spectrum disorders in the second trimester].
    Chen L; Wang Y; Liang SY; Shi HF; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):489-494. PubMed ID: 37474321
    [No Abstract]   [Full Text] [Related]  

  • 8. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
    Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidisciplinary management of placenta accreta spectrum (PAS) within a single tertiary centre: A ten-year experience.
    Yasin N; Slade L; Atkinson E; Kennedy-Andrews S; Scroggs S; Grivell R
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):550-554. PubMed ID: 30565213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiopathogenesis and risk factors for placental accreta spectrum disorders.
    Ali H; Chandraharan E
    Best Pract Res Clin Obstet Gynaecol; 2021 Apr; 72():4-12. PubMed ID: 32753310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound scoring system for prenatal diagnosis of placenta accreta spectrum.
    Zhang J; Li H; Feng D; Wu J; Wang Z; Feng F
    BMC Pregnancy Childbirth; 2023 Aug; 23(1):569. PubMed ID: 37550654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical Management of the Placenta Accreta Spectrum: An Institutional Experience.
    Mitric C; Desilets J; Balayla J; Ziegler C
    J Obstet Gynaecol Can; 2019 Nov; 41(11):1551-1557. PubMed ID: 30948337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of distal haemostasis during caesarean delivery in women with placenta accreta spectrum disorders.
    Barinov SV; Shmakov RG; Medyannikova IV; Tirskaya YI; Kadtsyna TV; Lazareva OV; Razdobedina IN; Neustroyeva TN; Stepanov SS
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8778-8785. PubMed ID: 34794371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with peripartum hysterectomy in the setting of placenta accreta spectrum disorder.
    Overton E; Wen T; Friedman AM; Azad H; Nhan-Chang CL; Booker WA; Khoury-Collado F; Mourad M
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101174. PubMed ID: 37802412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center.
    Varlas VN; Bors RG; Birsanu S; Maxim B; Clotea E; Mihailov M
    J Med Life; 2021; 14(3):367-375. PubMed ID: 34377203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta.
    Cali G; Forlani F; Giambanco L; Amico ML; Vallone M; Puccio G; Alio L
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():36-41. PubMed ID: 24965977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent placenta increta: a complication of conservative management of presumed placenta accreta.
    Davis JD; Cruz A
    Obstet Gynecol; 1996 Oct; 88(4 Pt 2):653-4. PubMed ID: 8841240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.